SCHEMBL30633372

SCHEMBL30633372

CN(CCO)C(=O)Nc1cc(-c2ccc3[nH]nc(N)c3c2)ccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 12/20 0.45
▸ DYRK1A Q13627 5/20 0.43
▸ JAK3 P52333 4/20 0.43
▸ MAP4K4 O95819 4/20 0.43
▸ ROCK2 O75116 4/20 0.43
▸ ROCK1 Q13464 4/20 0.43
▸ PLK4 O00444 3/20 0.43
▸ DAPK3 O43293 3/20 0.43
▸ DYRK3 O43781 3/20 0.43
▸ CDK1 P06493 3/20 0.43
▸ CDK2 P24941 3/20 0.43
▸ MARK3 P27448 3/20 0.43
▸ TYK2 P29597 3/20 0.43
▸ CLK2 P49760 3/20 0.43
▸ CDK5 Q00535 3/20 0.43
▸ PRKCD Q05655 3/20 0.43
▸ PKN2 Q16513 3/20 0.43
▸ MARK2 Q7KZI7 3/20 0.43
▸ AURKB Q96GD4 3/20 0.43
▸ PRKD2 Q9BZL6 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26686208 1.00 JAK2 (0.45) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL30633368 0.90 JAK2 (0.38) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL26686340 0.80 JAK2 (0.56) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL26686173 0.80 MAPK1 (0.56) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL30633349 0.80 MAPK1 (0.56) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL31240315 0.79 MAPK1 (0.56) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL26685764 0.79 MAPK1 (0.56) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL30633294 0.78 MAPK1 (0.49) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL26685933 0.78 MAPK1 (0.49) JAK2DYRK1AJAK3MAP4K4ROCK2
SCHEMBL30633127 0.78 JAK2 (0.48) JAK2DYRK1AJAK3MAP4K4ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP claimed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN claimed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO claimed
EP-4705291-A1 IKK-ALPHA INHIBITORS Cancer Research Technology Limited (GB) 2026-03-11 — — EP disclosed
EP-4522597-A1 IKK INHIBITORS Cancer Research Technology Limited (GB) 2025-03-19 — — EP disclosed
CN-119562945-A IKK inhibitors 癌症研究技术有限公司 2025-03-04 — — CN disclosed
WO-2024228035-A1 IKK-ALPHA INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-11-07 — — WO disclosed
WO-2023218201-A1 IKK INHIBITORS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2023-11-16 — — WO disclosed
Send feedback